This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Academic Highlights

New Insights Into Genetics and Pathophysiology of Alzheimer’s Disease: What Are the Clinical and Therapeutic Implications?

Michael Mullan, M.D.; George Grossberg, M.D.; Ravi Anand, M.D.; and Albert Enz, M.D.

Published: September 30, 2000

Article Abstract

Click to enlarge page

Genetic findings have made an important contribution to the understanding of Alzheimer’s disease. The mutations in β-amyloid precursor protein (βAPP) and presenilin 1 (PS1) transmitted in a simple Mendelian manner have provided the basis for our understanding of the central role of β-amyloid in all cases of Alzheimer’s . Dr. Mullan suggested that whereas variability at the apolipoprotein E (APOE) locus is clearly associated with the occurrence of disease, for many other genes such clarity is less established.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: